Drinabant
Drinabant (INN; AVE-1625) is a drug that acts as a selective CB1 receptor antagonist, which was under investigation varyingly by Sanofi-Aventis as a treatment for obesity, schizophrenia, Alzheimer's disease, Parkinson's disease, and nicotine dependence. Though initially studied as a potential treatment for a variety of different medical conditions, Sanofi-Aventis eventually narrowed down the therapeutic indications of the compound to just appetite suppression. Drinabant reached phase IIb clinical trials for this purpose in the treatment of obesity but was shortly thereafter discontinued, likely due to the observation of severe psychiatric side effects including anxiety, depression, and thoughts of suicide in patients treated with the now-withdrawn rimonabant, another CB1 antagonist that wa
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Drinabant
Drinabant (INN; AVE-1625) is a drug that acts as a selective CB1 receptor antagonist, which was under investigation varyingly by Sanofi-Aventis as a treatment for obesity, schizophrenia, Alzheimer's disease, Parkinson's disease, and nicotine dependence. Though initially studied as a potential treatment for a variety of different medical conditions, Sanofi-Aventis eventually narrowed down the therapeutic indications of the compound to just appetite suppression. Drinabant reached phase IIb clinical trials for this purpose in the treatment of obesity but was shortly thereafter discontinued, likely due to the observation of severe psychiatric side effects including anxiety, depression, and thoughts of suicide in patients treated with the now-withdrawn rimonabant, another CB1 antagonist that wa
has abstract
Drinabant (INN; AVE-1625) es u ...... arrollado por Sanofi-Aventis.
@es
Drinabant (INN; AVE-1625) is a ...... o approved treatments for ACO.
@en
CAS number
358970-97-5
FDA UNII code
61S98RLL5I
PubChem
Wikipage page ID
35,805,433
page length (characters) of wiki page
Wikipage revision ID
999,726,561
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChemSpiderID
image
@en
IUPAC name
-N-{1-[Bismethyl]-3-azetidinyl}-N-methanesulfonamide
@en
legal status
Development terminated
@en
PubChem
10,278,470
SMILES
Fc1ccNSC
@en
StdInChIKey
IQQBRKLVEALROM-UHFFFAOYSA-N
@en
wikiPageUsesTemplate
hypernym
comment
Drinabant (INN; AVE-1625) es u ...... mientos suicidas en pacientes
@es
Drinabant (INN; AVE-1625) is a ...... another CB1 antagonist that wa
@en
label
Drinabant
@en
Drinabant
@es